There is a catalyst for GLP-1 in the second quarter. A new design that can be administered orally from a syringe. Obesity-related. I think it will rise similarly to IBRX and ALT.
Let's meet at $15👋
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more